Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
5.20
-0.22 (-4.06%)
Aug 22, 2025, 5:29 PM CET

Egetis Therapeutics AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
47.346.157.622.638.240.66
Upgrade
47.346.157.622.638.240.66
Upgrade
Revenue Growth (YoY)
-33.19%-19.96%154.87%-40.84%-6.05%-50.75%
Upgrade
Cost of Revenue
28.411.611142.696.6185.17
Upgrade
Gross Profit
18.934.546.6-120-58.4-144.51
Upgrade
Selling, General & Admin
208.5215.3172.874.344.632.15
Upgrade
Research & Development
139.8146.2194---
Upgrade
Other Operating Expenses
-8.3-5.2-8.9--0.3-
Upgrade
Operating Expenses
340356.3357.97746.832.55
Upgrade
Operating Income
-321.1-321.8-311.3-197-105.2-177.06
Upgrade
Interest Expense
-21.7-17.6-4.2-0.1-0.2-0
Upgrade
Interest & Investment Income
12.76.94.90.90.10.16
Upgrade
Currency Exchange Gain (Loss)
-6.3-6.3-13.42.40.6-1.13
Upgrade
Other Non Operating Income (Expenses)
-0.5-4.5-2.8-0.20
Upgrade
Pretax Income
-336.9-343.3-326.8-193.8-104.5-178.02
Upgrade
Income Tax Expense
0.30.30.1---
Upgrade
Net Income
-337.2-343.6-326.9-193.8-104.5-178.02
Upgrade
Net Income to Common
-337.2-343.6-326.9-193.8-104.5-178.02
Upgrade
Shares Outstanding (Basic)
35930725719418067
Upgrade
Shares Outstanding (Diluted)
35931126019418067
Upgrade
Shares Change (YoY)
27.95%19.57%33.86%7.97%166.96%30.54%
Upgrade
EPS (Basic)
-0.94-1.12-1.27-1.00-0.58-2.64
Upgrade
EPS (Diluted)
-0.94-1.12-1.30-1.00-0.60-2.64
Upgrade
Free Cash Flow
-242.7-227.9-278.4-173.5-130.3-134.66
Upgrade
Free Cash Flow Per Share
-0.68-0.73-1.07-0.89-0.72-2.00
Upgrade
Gross Margin
39.96%74.84%80.90%--152.88%-
Upgrade
Operating Margin
-678.86%-698.05%-540.45%-871.68%-275.39%-435.43%
Upgrade
Profit Margin
-712.90%-745.34%-567.53%-857.52%-273.56%-437.81%
Upgrade
Free Cash Flow Margin
-513.11%-494.36%-483.33%-767.70%-341.10%-331.18%
Upgrade
EBITDA
-317.6-319.1-310.2-195.8-104-176.88
Upgrade
EBITDA Margin
-----272.25%-
Upgrade
D&A For EBITDA
3.52.71.11.21.20.18
Upgrade
EBIT
-321.1-321.8-311.3-197-105.2-177.06
Upgrade
EBIT Margin
-----275.39%-
Upgrade
Revenue as Reported
---22.638.540.66
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.